Rice Biotech Launch Pad invents 'living pharmacy' designed to produce therapeutics inside the body

Trial StartLiving pharmacy implantPositive

AI Analysis

Summary

Rice Biotech Launch Pad announced a 'living pharmacy' implant technology designed to produce therapeutics inside the body with multiple applications and year-long durability, expected to enter clinical trials in 2027. The approach aims to address the high cost and access limitations of biologic medicines.

Outcome Details

Durable implant designed to produce therapeutics inside the body, expected to last full year

Importance:6/10

Sentiment:

0.60

implant technologybiologic medicinesdrug deliverynovel therapeutic approachcost reduction

Read the original article

Published by PR Newswire Clinical Trials on October 2, 2026 6:01 PM

Read Original